Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Scientific Papers of Interest
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Scientific Papers of Interest
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2024 November
  • Home
  • Archive for November, 2024
A conversation with a genius lightbulb

Ross Youngs “A conversation with a genius”

  • November 27 2024

By Ross Youngs, November 27, 2024 “A conversation with a genius” Key points: The bottleneck in drug discovery suggests we need 1,000,000,000,000,000,000,000,000,000 years or more. Even with generous assumptions and the full force of global computing power, creating and testing all possible drug-like molecules within a reasonable timeframe remains a distant prospect. However, this thought experiment

Continue Reading

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact

  • November 12 2024

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact (November 12, 2024) by Nick Paul Taylor. ovartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs and identify

Continue Reading

RSS Industry News

  • Next-generation probiotics: an outlook into current applications and future developments May 8 2026
  • How a passion for baking fermented a fresh career move May 8 2026
  • The gut–joint axis in osteoarthritis May 7 2026
  • Surgically reshaping the gut microbiome May 7 2026
  • Comprehensive cross-cohort analysis reveals global gut microbiome signatures of celiac disease May 7 2026
  • Genome-wide sweeps create ecological units in the human gut microbiome May 6 2026
  • Practical lessons from microbiome citizen-science projects May 4 2026
  • Probiotics mitigate non-antibiotic drug-induced dysbiosis via protein homology-driven competitive binding May 4 2026
  • A Muribaculaceae-enriched microbiota exacerbates TLR4-dependent Acinetobacter baumannii-induced hyperinflammatory sepsis April 30 2026
  • Navigating the translational labyrinth of the gut microbiota April 29 2026
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism
  • Kailera Plans IPO for Obesity Drug That Could Top Lilly’s Zepbound
  • Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2026. All Rights Reserved.